Metronomic Chemotherapy by Cyclophosphamide Versus Megestrol in Palliative Cancer

Update Il y a 4 ans
Reference: NCT00420563

Woman and Man

  • | Country :
  • France
  • | organs :
  • -
  • | Specialty :
  • -

Extract

The scope of the trial is to assess the free progression rate at 2 months for each group of patients.


Inclusion criteria

  • Cancer

Links